AJTMH Transactions of the Royal Society of Tropical Medicine and Hygiene
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am. J. Trop. Med. Hyg., 56(3), 1997, pp. 315-317
Copyright © 1997 by The American Society of Tropical Medicine and Hygiene

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gay, F.
Right arrow Articles by Danis, M. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gay, F.
Right arrow Articles by Danis, M. M.

In Vitro Response of Plasmodium falciparum to Atovaquone and Correlation with other Antimalarials: Comparison between African and Asian Strains

Frederick Gay, Dorina Bustos, Boubacar Traore, Catherine Jardinel, Manivanh Southammavong, Liliane Ciceron AND M. Martin Danis
Laboratoire d'Epidemiologie et de Chimioresistance du Paludisme, Departement de Medecine Tropicale, Groupe Hospitalier Pitie-Salpetriere, Paris, France; Research Institute for Tropical Medicine, Department of Health, Metro Manila, The Philippines

Atovaquone (dihydroxynaphthoquinone 566C80) is a broad-spectrum antiprotozoal compound demonstrating potent antimalarial activity against multidrug-resistant malaria. We present the results of in vitro drug sensitivity tests of 142 Plasmodium falciparum isolates, 108 from 14 countries of West and Central Africa, 32 from the Philippines, and one each from Laos and Myanmar. These were tested in vitro against nine drugs: the classic antimalarials chloroquine, quinine, mefloquine and halofantrine, the four qinghaosu derivatives, artemisinin, artemether, artesunate, and arteether, and the new compound atovaquone. Results showed the Asian strains have a higher median 50% inhibitory concentration (IC50) to almost all drugs compared with those from Africa. This was significantly different for chloroquine, halofantrine, and artemisinin. We used three different approaches to estimate the threshold for resistance of atovaquone to be approximately 5–7 nmol/L. The global median of 96 pooled strains is 1.4 nmol/L and the 90th percentile is 5.5 nmol/L for atovaquone. There were no correlations of atovaquone with the eight other antimalarials among African strains, but significant correlations, except for halofantrine, were observed among Asian strains. The absence of a correlation between atovaquone and the other available drugs indicates the potential of atovaquone as an alternative antimalarial in Africa. The correlation observed among Asian strains, however, suggests that atovaquone has to be used cautiously in Asia. Nevertheless, the association with proguanil in recently concluded clinical trials in Europe, South America, Asia, and Africa has demonstrated its antimalarial efficacy.




This article has been cited by other articles:


Home page
Am J Trop Med HygHome page
S. KRUDSOOD, S. N. PATEL, N. TANGPUKDEE, W. THANACHARTWET, W. LEOWATTANA, K. PORNPININWORAKIJ, A. K. BOGGILD, S. LOOAREESUWAN, and K. C. KAIN
EFFICACY OF ATOVAQUONE-PROGUANIL FOR TREATMENT OF ACUTE MULTIDRUG-RESISTANT PLASMODIUM FALCIPARUM MALARIA IN THAILAND
Am J Trop Med Hyg, April 1, 2007; 76(4): 655 - 658.
[Abstract] [Full Text] [PDF]


Home page
Am J Trop Med HygHome page
A. K. BOGGILD, M. E. PARISE, L. S. LEWIS, and K. C. KAIN
ATOVAQUONE-PROGUANIL: REPORT FROM THE CDC EXPERT MEETING ON MALARIA CHEMOPROPHYLAXIS (II)
Am J Trop Med Hyg, February 1, 2007; 76(2): 208 - 223.
[Abstract] [Full Text] [PDF]


Home page
Am J Trop Med HygHome page
M. HENRY, I. DIALLO, J. BORDES, S. KA, B. PRADINES, B. DIATTA, P. S. M'BAYE, M. SANE, M. THIAM, P. M. GUEYE, et al.
Urban malaria in dakar, senegal: chemosusceptibility and genetic diversity of Plasmodium falciparum isolates.
Am J Trop Med Hyg, July 1, 2006; 75(1): 146 - 151.
[Abstract] [Full Text] [PDF]


Home page
J Antimicrob ChemotherHome page
L. Musset, B. Pradines, D. Parzy, R. Durand, P. Bigot, and J. Le Bras
Apparent absence of atovaquone/proguanil resistance in 477 Plasmodium falciparum isolates from untreated French travellers
J. Antimicrob. Chemother., January 1, 2006; 57(1): 110 - 115.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1997 by the American Society of Tropical Medicine and Hygiene.